Citeline, Trialtrove

2020 Clinical Trials Roundup: Disruptions to the Trial Landscape

25 Nov 2022

Our annual analysis dissects the data of all Phase I–III clinical trials that started in a year dominated by COVID-19.

Scrip

Pfizer Lays Out Multi-Phase COVID-19 Vaccine Commercial Strategy

By Jessica Merrill 14 Nov 2022

The pandemic phase will last through late 2021/early 2022, becoming a more seasonal opportunity for several years after, Pfizer management predicted during the company's second quarter call.

Q2 2021 Clinical Trials and the COVID-19 Vaccine Pulse Report

By Karen Currie 03 Jun 2021

The goal of our second Clinical Trials & the COVID-19 Vaccine Pulse Report is to uncover who is still hesitant to take a vaccine, and what public health experts from pharma to the U.S. government can do to turn the tide.

Biomedtracker, Datamonitor Healthcare

2020 Deal-Making Roundup

21 May 2021

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

Trialtrove

2020 Completed Trials A Bumpy Road for Industry Sponsored Clinical Studies

20 May 2021

Over the past five years, our analysis of completed trials consistently observed growth trends.

Clinical Trial Webinar Series

01 Apr 2021

Learn about the latest trends affecting biopharma R&D including, study diversity & transparency, predictive feasibility and more...

Citeline Connect

COVID-19 Trial Recruitment at Warp Speed

24 Mar 2021

Learn how Citeline Connect supported the fastest-recruiting COVID-19 clinical trial in operation warp speed history

Generics Bulletin

EU Reforms Must Heed Pandemic Lessons

By David Wallace 08 Dec 2020

Reforms set out by the European Commission to better prepare the EU for future health crises must heed key lessons learned from experiences of the COVID-19 pandemic, such as the benefits of digitalization, Medicines for Europe has urged